Quantitative LC/ESI-SRM/MS of antibody biopharmaceuticals: use of a homologous antibody as an internal standard and three-step method development
Crossref DOI link: https://doi.org/10.1007/s00216-017-0488-2
Published Online: 2017-07-14
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Osaki, Fumio
Tabata, Kenji
Oe, Tomoyuki
License valid from 2017-07-14